Skip directly to content

TCIs

Education Resource Center: Topical, Prescription, Steroid-Free Options for Eczema

There are 2 topical prescription eczema drugs that do not contain steroids. These are called topical immunomodulators or TIMs. Both are effective in treating the itch and rash of eczema. Neither causes certain side effects, such as thinking of the skin (atophy), or stretch marks (striae), spider veins or discoloration of the skins.

One of them is Elidel® (pimecrolimus). Elidel is a steroid-free cream for patients aged 2 years and older who have mild-to-moderate eczema.
The other topical immunomodulator is Protopic® (tacrolimus). It is a steroid-free ointment for patients aged 2 years and

Education Resource Center: Using Topical Prescription Steroids

Topical steroids are commonly prescribed to treat eczema. Steroids come in many strengths – low, mid, high, and ultra-high.

Education Resource Center: Using Prescription Creams and Ointments

People with eczema often need prescription medications to control their symptoms. If you are using prescription drugs to treat your eczema, it is important to talk with your doctor about how to use them properly and what you should expect from them.

Education Resource Center: Topical, Prescription, Steroid-free Options

There are 2 topical prescription eczema drugs that do not contain steroids. These are called topical immunomodulators or TIMs. Both are effective in treating the itch and rash of eczema.

Hand Dermatitis, or My Hands are Killing Me!

By Dr. Sunil Sharon Dhawan. What is hand dermatitis? Well, it’s any chronic rash on the hands. It is usually symptomatic; it itches, burns, bleeds, irritates, et cetera. About 2 to 9 percent of the general population has it, and a lot of people in my practice and a lot of people in most dermatology practices have it.

NEA-Funded Research Report Offers Independent Guidance regarding the Use of Two Popular Eczema Drugs

A report released in October 2005 by the National Eczema Association (NEA) offers guidance to both patients and physicians regarding the use of two common skin care medications that have been the subject of public health advisories by the Food and Drug Administration (FDA). In the NEA report, physicians from Brigham and Women’s Hospital (BWH) in Boston, Massachusetts, provide an independent review of the clinical benefits and potential cancer risks associated with the drugs Elidel (pimecrolimus) and Protopic (tacrolimus).